Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
肾病康复丸 (Shenbing Kangfu Wan) is a Traditional Chinese Medicine (TCM) formulation primarily used for the treatment of kidney-related conditions, including primary nephrotic syndrome, pediatric nephrotic syndrome, and membranous nephropathy. Its therapeutic approach in TCM is described as clearing heat and detoxifying, promoting diuresis and reducing swelling, activating blood and dispelling stasis, and tonifying kidney and astringing essence. It is also associated with the "warming yang and promoting diuresis method" (温阳利水法). Clinical observations and studies have investigated its efficacy in improving symptoms and kidney function in patients with these conditions. It is contraindicated for individuals with spleen and kidney yang deficiency.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 肾病康复丸.